Practical pointers for grappling with GERD. Heartburn gnaws at quality of life for many patients

Postgraduate Medicine

Volumn 105, Issue 7, 1999, Pages 88-106

  Szarka, Lawrence A ^a   Locke, Giles R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; ANTACID AGENT; AXID PULVULES; CALCIUM CARBONATE; CIMETIDINE; CISAPRIDE; CLARITHROMYCIN; ERYTHROMYCIN; FAMOTIDINE; FLUCONAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; MACROLIDE; MAGNESIUM HYDROXIDE; METOCLOPRAMIDE; METRONIDAZOLE; NIZATIDINE; OMEPRAZOLE; PRISOLEC; PROTON PUMP INHIBITOR; RANITIDINE; UNCLASSIFIED DRUG;

BARRETT ESOPHAGUS; CONFERENCE PAPER; CONSTIPATION; DIAGNOSTIC APPROACH ROUTE; DIARRHEA; DISEASE SEVERITY; DRUG INDUCED DISEASE; ESOPHAGITIS; ESOPHAGOSCOPY; ESOPHAGUS STRICTURE; FATIGUE; GASTROESOPHAGEAL REFLUX; GYNECOMASTIA; HEADACHE; HEARTBURN; HUMAN; LETHARGY; LIFESTYLE; LOWER ESOPHAGUS SPHINCTER; ORAL DRUG ADMINISTRATION; PATHOGENESIS; QUALITY OF LIFE;

EID: 0033003183     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1999.06.618     Document Type: Conference Paper

References (31)

1. Locke GR 3d, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112(5):1448-56
2. Locke GR 3d. The epidemiology of functional gastrointestinal disorders in North America. Gastroenterol Clin North Am 1996; 25(1):1-19
3. Gallup Survey. Heartburn across America. Princeton, NJ: Gallup Organization, 1998 Mar 24
4. Revicki DA, Wood M, Maton PN, et al. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 1998;104(3):252-8
5. Glise H, Hallerback B, Johansson B. Quality of life assessments in the evaluation of gastroesophageal reflux and peptic ulcer disease before, during and after treatment. Scand J Gastroenterol Suppl 1995;208:133-5
6. Dent J. Patterns of lower esophageal sphincter function associated with gastroesophageal reflux. Am J Med 1997;103(5A):29-32S
7. Holloway RH, Dent J. Pathophysiology of gastroesophageal reflux: lower esophageal sphincter dysfunction in gastroesophageal reflux disease. Gastroenterol Clin North Am 1990;19(3):517-35
8. Mittal RK, McCallum RW. Characteristics and frequency of transient relaxations of the lower esophageal sphincter in patients with reflux esophagitis. Gastroenterology 1988;95(3):593-9
9. Vaezi MF, Richter JE. Contribution of acid and duodenogastro-oesophageal reflux to oesophageal mucosal injury and symptoms in partial gastrectomy patients. Gut 1997;41(3):297-302
10. Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990;335(8683):205-8
11. Sontag SJ. Rolling review: gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1993;7(3):293-312
12. Traube M. The spectrum of the symptoms and presentations of gastroesophageal reflux disease. Gastroenterol Clin North Am 1990; 19(3):609-16
13. el-Serag HB, Sonnenberg A. Associations between different forms of gastro-oesophageal reflux disease. Gut 1997:41(5):594-9
14. Jaspersen D, Schwacha H, Schorr W, et al. Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease. J Gastroenterol Hepatol 1996;11(10):900-2
15. Falk GW. Barrett's esophagus. Gastrointest Endosc Clin North Am 1994;4(4):773-89
16. Cameron AJ, Zinsmeister AR, Ballard DJ, et al. Prevalence of columnar-lined (Barrett's) esophagus: comparison of population-based clinical and autopsy findings. Gastroenterology 1990;99(4):918-22
17. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997;26(3):487-94
18. Cameron AJ. Management of Barrett's esophagus. Mayo Clin Proc 1998;73(5):457-61
19. Hogan WJ. Spectrum of supraesophageal complications of gastroesophageal reflux disease. Am J Med 1997;103(5A):77-83S
20. Schindlbeck NE, Wiebecke B, Klauser AG, et al. Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease. Gut 1996;39(2):151-4
21. Kahrilas PJ, Hogan WJ. Gastroesophageal reflux disease. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal disease: pathophysiology, diagnosis, management. 5th ed. Philadelphia: Saunders, 1993:378-90
22. Ott DJ, Dodds WJ, Wu WC, et al. Current status of radiology in evaluating for gastroesophageal reflux disease. J Clin Gastroenterol 1982;4(4):365-75
23. 2-receptor antagonists: standard therapy for acid-peptic diseases. Part 1. N Engl J Med 1990; 323(24):1672-80
24. Physicians' desk reference. 51st ed. Montvale, NJ: Medical Economics, 1997:1182, 1468, 1763, 2694
25. Kahrilas PJ. Gastroesophageal reflux disease. JAMA 1996; 276(12):983-8
26. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95(4):903-12
27. 24 p 516
28. Sontag SJ. Rolling review: gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1993;7(3):293-312
29. Wysowski DK, Bacsanyi J. Cisapride and fatal arrhythmia. N Engl J Med 1996;335(4):290-1
30. Hendel J, Hendel L, Hage E, et al. Monitoring of omeprazole treatment in gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 1996;8(5):417-20
31. Hill LD, Aye RW, Ramel S. Antireflux surgery: a surgeon's look. Gastroenterol Clin North Am 1990;19(3):745-75